Latest Health News

Icon Energy Limited holds steady with $294,000 cash as it awaits key regulatory decisions on ATP 855 renewal and Petroleum Lease PL-1144, facing a looming ASX suspension deadline.

Legacy Iron Ore Limited reported a positive operating cash flow for Q3 2025, boosting its cash reserves to over A$10 million, supported by ongoing service agreements and the conclusion of a major infrastructure deal.

Peppermint Innovation Ltd reports strong quarterly progress with new payment functionalities live, a key merchant licence granted, and a strategic pivot toward AI-driven lending.

Australian Agricultural Projects Ltd has delivered a solid quarterly update with strong sales from its 2025 olive oil harvest and a stable orchard condition, while navigating rising water costs and international price pressures.

Cobalt Blue Holdings advances its Kwinana Cobalt Refinery with a critical Works Approval and secures letters of intent covering 70% of initial production, while its Broken Hill Cobalt Project gains a three-year Major Project Status extension.

Careteq Limited signals progress on its 1-System platform integration with a planned Q3 FY26 restart, while Embedded Health Solutions expands aged care contracts and the company navigates a significant ATO R&D tax objection.

Kingsgate Consolidated Ltd reported a record September quarter at its Chatree Gold Mine, with gold production surging 18% to nearly 24,000 ounces and silver output exceeding 200,000 ounces. Strong metal prices and operational efficiencies lifted cash and bullion holdings to A$115 million.

Desane Group Holdings has declared a special 2 cent per share dividend following the sale of a key property in Lane Cove, signalling a direct return of capital to shareholders.

4DMedical Limited has secured FDA clearance and immediate Medicare reimbursement for its groundbreaking CT – VQ™ lung imaging technology, accelerating commercial adoption across the US, Brazil, and Australia.

Patrys Limited has raised $1.77 million through a fully underwritten entitlement offer to fund preclinical studies and business development for its deoxymab therapeutic antibodies. The company also completed a capital consolidation and held a successful AGM, signaling a strategic pivot into immunology and inflammation.

CONNEQT Health reports robust 50% quarter-on-quarter growth in Pulse device sales and launches a new pricing strategy to boost recurring revenue. The company also secures a significant US clinical trial contract and advances cost-cutting efforts.

Cleo Diagnostics has successfully completed Stage 1 of the Medical Device Single Audit Program, marking a significant step toward FDA submission and global commercialisation of its ovarian cancer test.